ArticleActive
Billing and Coding: MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis
A59871
Updated: December 31, 2025
Policy Summary
This article provides billing and coding instructions for molecular testing for hereditary transthyretin amyloidosis as a complement to LCD DL39948. Only one test may be billed per patient with one unit of service; appropriate CPT and ICD-10-CM codes must be selected and the DEX Z-Code identifier must be entered adjacent to the CPT code in the specified Part A and Part B claim fields, taking care not to add extra characters on SV101-7.
Coverage Criteria Preview
Key requirements from the full policy
"This billing/coding guidance applies to molecular testing for identification and management of hereditary transthyretin amyloidosis when the test meets the coverage criteria of LCD DL39948."
Sign up to see full coverage criteria, indications, and limitations.